Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Capacity Building | 2 | 2015 | 257 | 0.790 |
Why?
|
Vietnam | 7 | 2022 | 411 | 0.670 |
Why?
|
HIV Infections | 9 | 2022 | 17165 | 0.460 |
Why?
|
Public Sector | 1 | 2015 | 265 | 0.450 |
Why?
|
Education, Nursing, Continuing | 1 | 2013 | 70 | 0.440 |
Why?
|
Carbapenems | 3 | 2022 | 123 | 0.360 |
Why?
|
beta-Lactam Resistance | 2 | 2020 | 74 | 0.300 |
Why?
|
Telemedicine | 2 | 2022 | 3018 | 0.270 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5325 | 0.200 |
Why?
|
Gene Transfer, Horizontal | 1 | 2022 | 144 | 0.190 |
Why?
|
Quality Improvement | 1 | 2015 | 3836 | 0.170 |
Why?
|
Microbial Sensitivity Tests | 2 | 2019 | 1949 | 0.170 |
Why?
|
Nasopharynx | 1 | 2022 | 394 | 0.170 |
Why?
|
Program Evaluation | 3 | 2020 | 2493 | 0.170 |
Why?
|
Adaptation, Biological | 1 | 2020 | 147 | 0.160 |
Why?
|
Klebsiella pneumoniae | 1 | 2020 | 255 | 0.150 |
Why?
|
RNA, Bacterial | 1 | 2019 | 385 | 0.150 |
Why?
|
Nucleic Acid Hybridization | 1 | 2019 | 1304 | 0.140 |
Why?
|
R Factors | 1 | 2017 | 44 | 0.140 |
Why?
|
Health Facilities | 1 | 2022 | 578 | 0.140 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2019 | 1006 | 0.140 |
Why?
|
Health Personnel | 3 | 2022 | 3310 | 0.140 |
Why?
|
Virulence | 1 | 2020 | 1298 | 0.130 |
Why?
|
Social Stigma | 1 | 2022 | 734 | 0.130 |
Why?
|
Anti-Retroviral Agents | 3 | 2022 | 1779 | 0.130 |
Why?
|
Enterobacteriaceae | 1 | 2017 | 172 | 0.130 |
Why?
|
Bacteremia | 2 | 2013 | 980 | 0.120 |
Why?
|
Medical Assistance | 1 | 2015 | 107 | 0.120 |
Why?
|
Enterobacteriaceae Infections | 1 | 2017 | 192 | 0.120 |
Why?
|
Nuclear Family | 1 | 2015 | 313 | 0.120 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2013 | 56 | 0.110 |
Why?
|
Models, Nursing | 1 | 2013 | 45 | 0.110 |
Why?
|
Education, Medical, Undergraduate | 1 | 2022 | 1066 | 0.110 |
Why?
|
DNA Transposable Elements | 1 | 2017 | 756 | 0.110 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1055 | 0.100 |
Why?
|
Evolution, Molecular | 1 | 2020 | 1885 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2022 | 5201 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1933 | 0.090 |
Why?
|
Actinomycetales | 1 | 2011 | 31 | 0.090 |
Why?
|
Actinomycetales Infections | 1 | 2011 | 30 | 0.090 |
Why?
|
Pleurisy | 1 | 2011 | 54 | 0.090 |
Why?
|
Models, Educational | 1 | 2013 | 373 | 0.090 |
Why?
|
Urine | 1 | 2012 | 363 | 0.090 |
Why?
|
Anti-Bacterial Agents | 3 | 2022 | 7408 | 0.090 |
Why?
|
Bacteria | 2 | 2019 | 2199 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2013 | 662 | 0.090 |
Why?
|
Cytomegalovirus | 1 | 2013 | 755 | 0.080 |
Why?
|
Substance Abuse, Intravenous | 1 | 2013 | 530 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4700 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4742 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2569 | 0.070 |
Why?
|
Humans | 24 | 2022 | 760621 | 0.070 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1758 | 0.070 |
Why?
|
Program Development | 1 | 2013 | 1297 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2592 | 0.070 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 694 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5649 | 0.070 |
Why?
|
Educational Measurement | 1 | 2013 | 1248 | 0.070 |
Why?
|
Epitope Mapping | 2 | 2004 | 297 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8056 | 0.070 |
Why?
|
Kidney | 1 | 2021 | 7064 | 0.060 |
Why?
|
Liver | 1 | 2021 | 7509 | 0.060 |
Why?
|
Zygomycosis | 1 | 2004 | 7 | 0.060 |
Why?
|
Staphylococcal Infections | 1 | 2013 | 1407 | 0.060 |
Why?
|
Gene Products, nef | 1 | 2004 | 100 | 0.060 |
Why?
|
HIV Core Protein p24 | 1 | 2004 | 245 | 0.060 |
Why?
|
Nurses | 1 | 2013 | 2467 | 0.060 |
Why?
|
HIV-1 | 3 | 2008 | 6849 | 0.060 |
Why?
|
Gene Products, gag | 1 | 2004 | 312 | 0.060 |
Why?
|
Genome, Bacterial | 2 | 2020 | 770 | 0.050 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2004 | 824 | 0.050 |
Why?
|
Immunodominant Epitopes | 1 | 2004 | 241 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25942 | 0.050 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2008 | 611 | 0.050 |
Why?
|
Drug Resistance, Viral | 1 | 2008 | 859 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9994 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8624 | 0.050 |
Why?
|
Phylogeny | 2 | 2020 | 2775 | 0.050 |
Why?
|
RNA | 1 | 2012 | 2722 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2022 | 58995 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2004 | 4353 | 0.050 |
Why?
|
Antigen-Antibody Reactions | 1 | 2021 | 346 | 0.050 |
Why?
|
Pilot Projects | 1 | 2013 | 8555 | 0.040 |
Why?
|
Protein Structure, Quaternary | 1 | 2021 | 428 | 0.040 |
Why?
|
Curriculum | 1 | 2013 | 3718 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 1 | 2021 | 419 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 241 | 0.040 |
Why?
|
Counseling | 1 | 2008 | 1548 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4783 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 296 | 0.040 |
Why?
|
Antigen-Antibody Complex | 1 | 2021 | 513 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 41335 | 0.040 |
Why?
|
Bacterial Capsules | 1 | 2020 | 242 | 0.040 |
Why?
|
Antifungal Agents | 1 | 2004 | 749 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 2020 | 915 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3986 | 0.040 |
Why?
|
Klebsiella Infections | 1 | 2020 | 147 | 0.040 |
Why?
|
Triazoles | 1 | 2004 | 904 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 653 | 0.040 |
Why?
|
Clone Cells | 2 | 2017 | 1660 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 979 | 0.040 |
Why?
|
Mycobacterium | 1 | 2019 | 250 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1007 | 0.040 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 77 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2021 | 642 | 0.040 |
Why?
|
Plasmids | 1 | 2022 | 2275 | 0.030 |
Why?
|
Adult | 8 | 2022 | 219994 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2021 | 1982 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 820 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1955 | 0.030 |
Why?
|
Middle Aged | 8 | 2022 | 220352 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2021 | 983 | 0.030 |
Why?
|
Young Adult | 1 | 2022 | 58741 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 783 | 0.030 |
Why?
|
Peptides | 2 | 2004 | 4354 | 0.030 |
Why?
|
Adolescent | 2 | 2022 | 87810 | 0.030 |
Why?
|
beta-Lactamases | 1 | 2017 | 304 | 0.030 |
Why?
|
Aged | 3 | 2022 | 169152 | 0.030 |
Why?
|
Urinary Tract Infections | 1 | 2020 | 814 | 0.030 |
Why?
|
Female | 9 | 2022 | 391270 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2005 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2838 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 2176 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1506 | 0.020 |
Why?
|
Viral Load | 1 | 2021 | 3322 | 0.020 |
Why?
|
Enterotoxins | 1 | 2013 | 366 | 0.020 |
Why?
|
Male | 7 | 2022 | 359744 | 0.020 |
Why?
|
Pyrimidines | 1 | 2004 | 3016 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2020 | 6216 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 18957 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4090 | 0.020 |
Why?
|
Herpesvirus 2, Human | 1 | 2012 | 191 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1462 | 0.020 |
Why?
|
Genotype | 2 | 2019 | 12960 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2380 | 0.020 |
Why?
|
Developing Countries | 1 | 2022 | 2868 | 0.020 |
Why?
|
DNA, Ribosomal | 1 | 2011 | 285 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2011 | 17624 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3143 | 0.020 |
Why?
|
Fungi | 1 | 2012 | 339 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54303 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3663 | 0.020 |
Why?
|
Zebrafish | 1 | 2020 | 2997 | 0.020 |
Why?
|
Blood | 1 | 2011 | 586 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3539 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4393 | 0.020 |
Why?
|
HIV Protease | 1 | 2008 | 97 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 2013 | 931 | 0.020 |
Why?
|
Species Specificity | 1 | 2012 | 2418 | 0.020 |
Why?
|
Cross Infection | 1 | 2017 | 1434 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9530 | 0.020 |
Why?
|
HIV Reverse Transcriptase | 1 | 2008 | 212 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 2012 | 753 | 0.020 |
Why?
|
Vision Disorders | 1 | 2013 | 1084 | 0.020 |
Why?
|
Primary Health Care | 1 | 2022 | 4647 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2011 | 1456 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3105 | 0.020 |
Why?
|
Microscopy | 1 | 2011 | 885 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2004 | 3157 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9411 | 0.020 |
Why?
|
National Health Programs | 1 | 2008 | 441 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2011 | 1296 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9185 | 0.010 |
Why?
|
Visual Acuity | 1 | 2013 | 2643 | 0.010 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 148 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9280 | 0.010 |
Why?
|
Drug Resistance, Fungal | 1 | 2004 | 73 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2017 | 3826 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12159 | 0.010 |
Why?
|
Erythrocytes | 1 | 2012 | 2415 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4264 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2004 | 630 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2004 | 13451 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 2012 | 1742 | 0.010 |
Why?
|
Aspergillosis | 1 | 2004 | 243 | 0.010 |
Why?
|
Cross Reactions | 1 | 2004 | 818 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16546 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12626 | 0.010 |
Why?
|
World Health Organization | 1 | 2008 | 1312 | 0.010 |
Why?
|
Genetic Variation | 1 | 2017 | 6551 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10756 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 2004 | 695 | 0.010 |
Why?
|
Mycoses | 1 | 2004 | 387 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15789 | 0.010 |
Why?
|
Prenatal Care | 1 | 2008 | 1129 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2013 | 3736 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4713 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2013 | 4491 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15289 | 0.010 |
Why?
|
Population Surveillance | 1 | 2008 | 2608 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15687 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22053 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20080 | 0.010 |
Why?
|
Hospitalization | 1 | 2013 | 10790 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 5496 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81208 | 0.010 |
Why?
|
Melanoma | 1 | 1991 | 5697 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1991 | 5799 | 0.010 |
Why?
|
Animals | 1 | 2020 | 167963 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20509 | 0.000 |
Why?
|
Risk Factors | 1 | 2013 | 74359 | 0.000 |
Why?
|
Pregnancy | 1 | 2008 | 29749 | 0.000 |
Why?
|
Mutation | 1 | 2008 | 29932 | 0.000 |
Why?
|
Child, Preschool | 1 | 2004 | 42063 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 65017 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1991 | 8552 | 0.000 |
Why?
|
Survival Analysis | 1 | 1991 | 10182 | 0.000 |
Why?
|
Survival Rate | 1 | 1991 | 12808 | 0.000 |
Why?
|
Prognosis | 1 | 1991 | 29658 | 0.000 |
Why?
|
Time Factors | 1 | 1991 | 40165 | 0.000 |
Why?
|
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(75)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_